Amlodipine Benzoate Patent Expiration

Amlodipine Benzoate is Used for managing hypertension and angina. It was first introduced by Azurity Pharmaceuticals Inc in its drug Katerzia on Jul 8, 2019. 2 different companies have introduced drugs containing Amlodipine Benzoate.


Amlodipine Benzoate Patents

Given below is the list of patents protecting Amlodipine Benzoate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Katerzia US10695329 Amlodipine formulations Oct 16, 2037 Azurity
Katerzia US10799453 Amlodipine formulations Apr 11, 2039 Azurity
Katerzia US10894039 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US10952998 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US10959991 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11364230 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11471409 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11484498 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11701326 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11918685 Amlodipine formulations Oct 06, 2037 Azurity


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Amlodipine Benzoate Generics

Only one generic application has been filed for Amlodipine Benzoate.

Given below is the list of companies who have filed for Amlodipine Benzoate generic.


1. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Amlodipine Benzoate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML suspension Discontinued ORAL N/A Jun 13, 2023